Markolines Pavem Q1 FY27 Results (NSE: MARKOLINES)

14 Aug 2026 · Analysis by Alpha Inflection

Signal: Margin expansion

The read

Q1FY27 marks a YoY margin recovery, with consolidated EBITDA margin expanding to 12.4% from 9.0% and EBITDA rising 27.7% despite revenue growth slowing to 4.3% from 46.0% in Q1FY26; however, standalone revenue fell 15.3% and 30% of consolidated PBT came from other income, so the durability of the operating improvement remains unproven.

P&L walk

Consolidated revenue increased 4.3% YoY to ₹75.86 Cr, EBITDA grew faster at 27.7% to ₹9.44 Cr and margin expanded to 12.4%, while PAT rose 15.0% to ₹4.36 Cr; the bottom line was partly supported by ₹1.75 Cr of other income, equal to 30% of PBT.

Segments

The group entities lifted consolidated performance: standalone revenue declined 15.3% to ₹61.6 Cr while consolidated revenue rose 4.3% to ₹75.86 Cr, with Markolines Evrascon JV reporting ₹14.2663 Cr revenue and ₹1.0193 Cr PAT but Uniqueuhpc Markolines LLP reporting a ₹1.0098 Cr loss.

Key positives

• Consolidated EBITDA increased 27.7% YoY to ₹9.44 Cr versus revenue growth of 4.3%, and EBITDA margin expanded 340bps YoY to 12.4%.
• Consolidated EBIT rose 35.4% YoY to ₹7.77 Cr, exceeding revenue growth and indicating improved operating conversion.
• Markolines Evrascon JV contributed ₹14.2663 Cr of revenue and ₹1.0193 Cr of PAT, helping offset the standalone revenue decline.

Key concerns

• Standalone revenue declined 15.3% YoY to ₹61.6 Cr, while consolidated growth was only 4.3%, signalling weak parent-level execution momentum.
• Other income of ₹1.75 Cr represented 30% of consolidated PBT and ₹2.51 Cr represented 45.1% of standalone PBT, reducing earnings quality.
• Revenue growth decelerated from 46.0% YoY in Q1FY26 to 4.3% in Q1FY27, despite the margin recovery.

Earnings quality: includes non-operating other income

View original filing

Research and educational content only. Not investment advice.